Gradual dose titration represents the cornerstone of minimizing adverse effects
Beyond weight loss and diabetes, GLP-1 therapies are being studied for conditions such as: Alzheimers and Parkinsons disease Non-alcoholic fatty liver disease (NAFLD) Polycystic ovary syndrome (PCOS) Final Thoughts: GLP-1 as a Metabolic Game Changer GLP-1 is more than just a gut hormone
Always consult a licensed healthcare provider before making decisions about medications or treatment plans
adults (margin of error +/- 3 percentage points)
The trial did report a skin-related effect, described as cutaneous hyperesthesia and skin sensitivity, in about 7% of people on retatrutide compared with 1% on placebo, but it did not report alopecia or hair loss as a distinct side effect
The pop-ups are not the most aggressive we have seen, and they dont follow into the patient portal, but the urgency framing is real and the discount is pegged to month one only